What's breaking now, across thousands of outlets.
Syngenis has joined Perron Institute and Gene S founders in a new precision-medicine venture that puts its integrated DNA and RNA biotech platform to work.
We haven't written up this one. The Age has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
Type 2 diabetes is increasingly affecting young adults in Germany, with new evidence showing poverty, low education and first-generation migration background as factors associated with the disease.
Many kids enjoy pretend play with imaginary pals or stuffed toys, fostering their communication skills. Engaging in this type of play is typical and does not necessarily indicate loneliness.
Public comment letters from hospital associations asked the administration to stick to the status quo where possible, highlighting changes they said offer no benefit and could lead to unnecessary…
Two sides agree to cooperate in developing improved seeds, livestock genetics, emerging agricultural technologies
The crisis facing the health system in Colombia can be well depicted with just a few strokes: this year could close with 60,000 complaints related to barriers to accessing this vital service, there are delays in the delivery of medications, difficulties in accessing general and specialized medical appointments, persistent cases of denial…
